Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012;12 Suppl 2(Suppl 2):S9.
doi: 10.1186/1471-2334-12-S2-S9. Epub 2012 Nov 12.

Future research and collaboration: the "SINERGIE" project on HCV (South Italian Network for Rational Guidelines and International Epidemiology)

C Torti  1 , M Zazzi, L Abenavoli, F Trapasso, F Cesario, D Corigliano, L Cosco, C Costa, R L Curia, M De Rosa, G Foti, C Giraldi, R Leone, M C Liberto, D Lucchino, N Marascio, R Masciari, G Matera, V Pisani, N Serrao, L Surace, E Zicca, F Castelli, M Ciccozzi, M Puoti, A Focà; SINERGIE Study Group
Affiliations
Review

Future research and collaboration: the "SINERGIE" project on HCV (South Italian Network for Rational Guidelines and International Epidemiology)

C Torti et al. BMC Infect Dis. 2012.

Abstract

The SINERGIE (South Italian Network for Rational Guidelines and International Epidemiology) project is intended to set up a collaborative network comprising virologists, clinicians and public health officials dealing with patients affected by HCV disease in the Calabria Region. A prospective observational data-base of HCV infection will be developed and used for studies on HCV natural history, response to treatment, pharmaco-economics, disease complications, and HCV epidemiology (including phylogenetic analysis). With this approach, we aim at improving the identification and care of patients, focusing on upcoming research questions. The final objective is to assist in improving care delivery and inform Public Health Authorities on how to optimize resource allocation in this area.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow of interventions and objectives of the SINERGIE study
See this image and copyright information in PMC

References

    1. Abenavoli L, Almasio PL. Chronic hepatitis C infection and insulin resistance: two best friends. Expert Rev Anti Infect Ther. 2011;9:555–558. - PubMed
    1. Bonner JE, Barritt AS 4th, Fried MW, Evon DM. Tangible resources for preparing patients for antiviral therapy for chronic hepatitis C. Dig Dis Sci. 2012;57:1439–1444. doi: 10.1007/s10620-012-2142-3. - DOI - PMC - PubMed
    1. Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guidelines by the American association for the study of liver diseases. Hepatology. 2011;54:1433–1444. doi: 10.1002/hep.24641. - DOI - PMC - PubMed
    1. Scotto G, Giammario A, Campanale F, D’Addiego G, Fazio V. Impact of interleukin-27 on replication of hepatitis C virus. International Journal of Interferon, Cytokine and Mediator Research. 2011;3:79–89.
    1. Simmonds P, Bukh J, Combet C, Deléage G, Enomoto N, Feinstone S, Halfon P, Inchauspé G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin-I T, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 2005;42:962–73. doi: 10.1002/hep.20819. - DOI - PubMed